COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,749 Articles (22,502 medRxiv, 8,247 bioRxiv)

Most recent first Previous |  Page 1092: Articles 10911-10920  | Next

SARS-CoV-2 Antibody Response is Associated with Age in Convalescent Outpatients
Zhai, B., Clarke, K., Bauer, D. L., Kupul, S., Schratz, L. J., Nowalk, M. P., McElroy, A. K., McLachlan, J. B., Zimmerman, R. K., Alcorn, J. F.
10.1101/2021.11.08.21265888 — Posted: 2021-11-08
Anti-membrane and anti-spike antibodies are long-lasting and together discriminate between past COVID-19 infection and vaccination
Amjadi, M. F., Adyniec, R. R., Gupta, S., Bashar, S. J., Mergaert, A. M., Braun, K. M., Moreno, G. K., O'Connor, D. H., Friedrich, T. C., Safdar, N., McCoy, S. S., Shelef, M. A.
10.1101/2021.11.02.21265750 — Posted: 2021-11-08
An interactome landscape of SARS-CoV-2 virus-human protein-protein interactions by protein sequence-based multi-label classifiers
Lee, H.-J.
10.1101/2021.11.07.467640 — Posted: 2021-11-08
Molecular signature of postmortem lung tissue from COVID-19 patients suggests distinct trajectories driving mortality
Budhraja, A., Basu, A., Gheware, A., Abhilash, D., Rajagopala, S., Pakala, S., Sumit, M., Ray, A., Arulselvi, S., Mathur, P., Nambirajan, A., Kumar, S., Gupa, R., Wig, N., Trikha, A., Guleria, R., Sarkar, C., Gupta, I., Jain, D.
10.1101/2021.11.08.467705 — Posted: 2021-11-08
SARS-COV-2 Delta variant displays moderate resistance to neutralizing antibodies and spike protein properties of higher soluble ACE2 sensitivity, enhanced cleavage and fusogenic activity
Neerukonda, S. N., Vassell, R., Lusvarghi, S., Wang, R., Echegaray, F., Bentley, L., Eakin, A. E., Erlandson, K. J., Katzelnick, L. C., Weiss, C. D., Wang, W.
10.1101/2021.11.05.467523 — Posted: 2021-11-08
Ethnicity and outcomes in COVID-19 in the United Kingdom: a systematic review and meta-analysis
Siddiq, S., Ahmed, S., Akram, I.
10.1101/2021.11.07.21266027 — Posted: 2021-11-08
Structural basis of main proteases of coronavirus bound to drug candidate PF-07321332
Li, J., Lin, C., Zhou, X., Zhong, F., Zeng, P., Jiang, H., Yang, Y., McCormick, P., Fu, Y., Zhang, J.
10.1101/2021.11.05.467529 — Posted: 2021-11-08
REGEN-COV for the Treatment of Hospitalized Patients with Covid-19
Somersan-Karakaya, S., Mylonakis, E., Menon, V. P., Wells, J. C., Ali, S., Sivapalasingam, S., Sun, Y., Bhore, R., Mei, J., Miller, J., Cupelli, L., Hooper, A. T., Hamilton, J. D., Pan, C., Pham, V., Zhao, Y., Hosain, R., Mahmood, A., Davis, J. D., Turner, K. C., Kim, Y., Cook, A., Kowal, B., Soo, Y., DiCioccio, A. T., Geba, G. P., Stahl, N., Lipsich, L., Braunstein, N., Herman, G. A., Yancopoulos, G. D., Weinreich, D. M., the Covid-19 Phase 2/3 Hospitalized Trial Team
10.1101/2021.11.05.21265656 — Posted: 2021-11-08
Surveillance of COVID-19 in a Vaccinated Population: A Rapid Literature Review
Egunsola, O., Farkas, B., Flanagan, J., Salmon, C., Mastikhina, L., Clement, F.
10.1101/2021.11.05.21265763 — Posted: 2021-11-08
Effect of the Neutralizing SARS-CoV-2 Antibody Sotrovimab in Preventing Progression of COVID-19: A Randomized Clinical Trial
Gupta, A., Gonzalez-Rojas, Y., Juarez, E., Crespo, M., Moya, J., Falci, D., Sarkis, E., Solis, J., Zheng, H., Scott, N., Cathcart, A. L., Parra, S., Sager, J. E., Austin, D. J., Peppercorn, A., Alexander, E., Yeh, W. W., Brinson, C., Aldinger, M., Shapiro, A. E.
10.1101/2021.11.03.21265533 — Posted: 2021-11-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).